Global Enrofloxacin Market Is Estimated To Witness High Growth Owing To Increasing Demand For Animal Derived Food Products

Enrofloxacin Market
Enrofloxacin Market

Overview:

Enrofloxacin is an antibiotic in the fluoroquinolone family that can be used to treat a wide variety of infections. This medication works by inhibiting DNA synthesis within bacteria, thus killing them. This is a broad spectrum antibiotic which means it can kill both Gram negative and positive bacteria. Unfortunately, bacterial resistance is a serious issue with this class of antibiotics and this drug should be used judiciously.

Generally, this medication is well-tolerated by most pets. The most common side effects are vomiting and diarrhea. This medication may interact with antacids, sucralfate, 3rd generation cephalosporins, clindamycin, theophylline and oral steroids. It may also decrease its effectiveness when mixed with tetracycline and macrolide antibiotics.

Market Dynamics:

Increasing product launches are estimated to augment growth of the global Enrofloxacin Market during the forecast period. For instance, TOXFIN CARE, was launched by Kemin in Europe, In November 2021. This new solution focuses on preventing loss in productivity and performance by safeguarding animal tissues and organs from damage caused due to mycotoxins. Moreover, increasing cost of animal healthcare drugs and services are anticipated to restrain growth of the global enrofloxacin for market during the forecast period.

Impact of COVID-19:

The pandemic was first reported in 2019 in China, and it affected millions of people. The pandemic also hampered the growth of many sectors in the countries. This outbreak also spread to many other nations globally, affecting millions of individuals globally. The pandemic had a huge impact on the healthcare sector. The number of patients suffering from COVID-19 were increasing on a daily basis and this caused an immense pressure on the healthcare sector.

There was a huge shortage of drugs, medical devices, hospital beds, and skilled professionals. So to overcome these shortages, all resources were used for treating COVID-19 patients and developing drugs and vaccines for COVID-19. This led to decrease in demand for enrofloxacin. Thus, the pandemic hampered the growth of the global enrofloxacin for market.

Key Takeaways:

The global Enrofloxacin Market is expected to witness robust growth, exhibiting CAGR of 3.6 % over the forecast period, due to rising product launches.

For instance, Kemin launched a new solution in Europe, TOXFIN CARE, in November 2021. This solution was focussing on preventing loss in performance and productivity by safeguarding animal organs and tissue from potential damage caused by mycotoxins.

North America is anticipated to witness robust growth in the global enrofloxacin for market during the forecast period, due to increasing adoption of pet animals and growing animal healthcare.

Key players active in the global Enrofloxacin Market are Pure Chemistry Scientific, BeiJing Hwrk Chemicals, LGM Pharma, Meryer Chemical Technology, BOC Sciences, J & K SCIENTIFIC, TCI, Guangzhou Isun Pharmaceutical, Toronto Research Chemicals, Waterstone Technology, Apollo Scientific and Ryan Scientific.

Comments

Popular posts from this blog

Biopreservation Have Become Important Tool For Bioengineering, Computer Sciences, Molecular Biology, And Cellular Biology

Cancer Biologics Is A Biological Therapy That Is Made By Reproducing, Or Growing, Cells In A Carefully Controlled Laboratory Setting

Gynecological Cancer Drugs Are Of Different Types and Are Used Depending On the Specific Needs of the Patient